Sclerosis News and Research

RSS

Multiple sclerosis genomic map implicates immune cells in disease susceptibility

The International Multiple Sclerosis Genetic Consortium reports the results of its latest study, "Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility", in the journal Science today: the highly productive collaborative group presents a new milestone in its efforts to understand the genetic basis of multiple sclerosis.

26 Sep 2019

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

There's no question that as body weight increases, so too does blood pressure. Now, in a study of mice, Johns Hopkins researchers have revealed exactly which molecules are likely responsible for the link between obesity and blood pressure.

From Johns Hopkins Medicine 26 Sep 2019

In tiny doses, an addiction medication moonlights as treatment for chronic pain

Lori Pinkley, a 50-year-old from Kansas City, Mo., has struggled with puzzling chronic pain since she was 15.

26 Sep 2019

Chan Zuckerberg Initiative supports a patient-led movement to cure ALS

The Chan Zuckerberg Initiative today announced $453,000 in funding for I AM ALS, a patient-led organization dedicated to raising awareness of Amyotrophic lateral sclerosis and empowering patients to lead the search for a cure.

25 Sep 2019

Does the brain thin as children grow?

Neuroscientists have long held that the brains of children thin down over time. However, this was on the basis of older imaging techniques. Now, using cutting-edge technology in the form of quantitative magnetic resonance imaging (qMRI), a team of researchers has found that the apparent thinning is due in part to myelin formation around the cortical nerve fibers. These very interesting findings, published in the journal PNAS on September 23, 2019, will drive further research on the link between cortical function and structure.

25 Sep 2019

Thinning of human brain during childhood linked with myelination

Using state-of-the-art brain imaging techniques, Vaidehi Natu at Stanford University in California, along with her colleagues from the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, provide striking results that suggest the brains of children likely do not thin as much as expected.

24 Sep 2019

Scientists to present new findings on gene therapy at Neuroscience 2019

Gene therapy shows promise as a way to treat and cure presently incurable neurological diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

24 Sep 2019

Scientists move one step closer to discovering the causes of immune diseases

Scientists are one step closer to discovering the causes of immune diseases such as asthma, multiple sclerosis and arthritis

23 Sep 2019

Researchers use high-throughput mutagenesis approach to study ALS

Amyotrophic lateral sclerosis is a devastating and incurable nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control and normally death within a few years of diagnosis.

23 Sep 2019

RNA hitches lysosome rides to make proteins far away from the nucleus

Proteins inside a cell are often made at the site where they are used, rather than being shipped long distances. This is so with nerve cells which have long cell extensions in the form of axons and dendrites, up to four feet long in some case

22 Sep 2019

Wearable brain-machine interface could help disabled people to control a wheelchair or vehicle

Combining new classes of nanomembrane electrodes with flexible electronics and a deep learning algorithm could help disabled people wirelessly control an electric wheelchair, interact with a computer or operate a small robotic vehicle without donning a bulky hair-electrode cap or contending with wires.

20 Sep 2019

Scientists link neuropsychological tests with real-life activity in MS patients

A recent review by Kessler Foundation researchers explored the relationship between neuropsychological assessment and predictability of performance of everyday life activities among people with multiple sclerosis (MS).

20 Sep 2019

Prilenia's lead compound selected to participate in first-ever ALS platform trial

Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).

19 Sep 2019

AAN recommends assessment of people aged 65 and older for memory problems

People with mild cognitive impairment have thinking and memory problems but usually do not know it because such problems are not severe enough to affect their daily activities.

19 Sep 2019

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

18 Sep 2019

Quanterix Serum Nf-L assay powers key trial and study results presented at ECTRIMS 2019

Quanterix, announce that its Simoa technology and Nf-L assays were used in many of the groundbreaking research and treatment developments.

From Quanterix 18 Sep 2019

Study shows how a toxin produced by algal blooms in saltwater may cause ALS

Can a computer be used to explain why an environmental toxin might lead to neurodegenerative disease? According to Penn State College of Medicine researchers, a computer generated-simulation allowed them to see how a toxin produced by algal blooms in saltwater might cause Amyotrophic Lateral Sclerosis.

17 Sep 2019

Plant-based diet could heal your rheumatoid arthritis

According to the latest review, adopting a plant-based diet could well relieve the swollen joints and pain of rheumatoid arthritis (RA).

13 Sep 2019

Brain changes may help track people most likely to develop dementia

Even before dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Sep 2019